Renovaro to Acquire Predictive Oncology in All-Stock Deal
January 6, 2025
Renovaro, an AI-powered cancer diagnostics and therapeutics company, entered into a binding LOI to acquire Predictive Oncology (POAI) in an all-stock transaction. The acquisition will allow Renovaro to combine Predictive Oncology’s large biobank and AI/ML platform with its own AI-driven liquid biopsy and cancer vaccine programs to accelerate biomarker discovery and expand clinical decision support capabilities.
- Buyers
- Renovaro
- Targets
- Predictive Oncology (POAI)
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Capital A Acquires Majority Stake in ARVOO Imaging Products
October 20, 2023
AI & Machine Learning
Capital A (Capital A Investment Partners) has acquired a majority stake in ARVOO Imaging Products to fund the company’s next growth phase and support international expansion. ARVOO’s management (CEO Fons Grijpink and CTO René Voorwinden) remain in operational control while Capital A will act as a sponsor to accelerate globalization and pursue a selective buy-and-build strategy.
-
Lumivero Acquires Risk Decisions
August 15, 2024
Software
Lumivero, a Denver-based data-intelligence software company, has acquired Risk Decisions Limited, the U.K. developer of the Predict! risk-management suite. The acquisition combines Risk Decisions' Predict! with Lumivero's @RISK capabilities to expand Lumivero's enterprise risk-management and decision-intelligence offerings.
-
Kailo Medical Acquires REI AI
May 21, 2025
AI & Machine Learning
Kailo Medical, a Melbourne-based provider of structured reporting and healthcare interoperability solutions, has acquired REI AI, a clinician-founded generative AI start-up focused on radiology reporting. The acquisition brings generative reporting capabilities into Kailo's product suite and appoints REI AI founder Dr. Reuben Schmidt as Director of Clinical AI to accelerate integration and clinical adoption.
-
Sun Nuclear (Mirion Medical) Acquires Oncospace
April 30, 2025
Healthcare Services
Sun Nuclear, a Mirion Medical company, has acquired Oncospace, a cloud-based, AI-powered radiation oncology software provider. The acquisition brings Oncospace’s predictive plan quality and treatment-planning conversion tools into Sun Nuclear’s software roadmap to expand its digital-first radiation therapy quality assurance capabilities.
-
Novartis Acquires Mariana Oncology
May 2, 2024
Biotechnology
Novartis will acquire Mariana Oncology for $1 billion upfront and up to $750 million in milestone payments, bringing Mariana's peptide-based radiopharmaceutical pipeline and manufacturing capabilities into Novartis. The deal adds radioligand therapeutic discovery, isotope supply chain and manufacturing know-how to Novartis to accelerate development and commercialization of targeted cancer therapies.
-
AstraZeneca Acquires Modella AI
January 15, 2026
AI & Machine Learning
AstraZeneca has acquired Modella AI, a Boston-based biomedical AI company, to integrate its multimodal foundation models and agentic AI platform into AstraZeneca's global oncology R&D organization. The deal expands an existing multi-year collaboration to accelerate clinical development, improve biomarker discovery, and drive data-driven decision-making across AstraZeneca's oncology pipeline; financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.